Möbius Syndrome: Misoprostol Use and Speech and Language Characteristics
Autor(a) principal: | |
---|---|
Data de Publicação: | 2014 |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UNIFESP |
Texto Completo: | http://dx.doi.org/10.1055/s-0033-1363466 http://repositorio.unifesp.br/handle/11600/8566 |
Resumo: | Introduction Möbius syndrome (MS; VI and VII palsy) is a rare disease that in Brazil has a great frequency because of the use of misoprostol during pregnancy. Objective Verify if the speech and language performance of children with MS whose mothers reported use of misoprostol (Cytotec, Pfizer, Connecticut, USA) are different from the performance of children of mothers who did not report use. Methods The stomatognathic system beyond receptive and expressive language and speech was evaluated in children with MS, and their mothers were questioned whether they used misoprostol during the pregnancy. Results During the interview, 61.11% of mothers reported that they took misoprostol during the pregnancy. Most of the subjects (83.3%) whose mothers took misoprostol presented bilateral palsy beyond bad mobility of the tongue (90.9%) and speech disorders (63.6%). Conclusion The number of mothers who took misoprostol without knowing the risk for MS was great. The lack of facial expressions and speech disorders were common characteristics of the individuals with MS, whether the mothers took misoprostol during the pregnancy or not. |
id |
UFSP_9e64ca2aa65780027c5fb5837c53c34b |
---|---|
oai_identifier_str |
oai:repositorio.unifesp.br/:11600/8566 |
network_acronym_str |
UFSP |
network_name_str |
Repositório Institucional da UNIFESP |
repository_id_str |
3465 |
spelling |
Möbius Syndrome: Misoprostol Use and Speech and Language Characteristicsmisoprostolspeech disordersrehabilitation of speech and language disordersIntroduction Möbius syndrome (MS; VI and VII palsy) is a rare disease that in Brazil has a great frequency because of the use of misoprostol during pregnancy. Objective Verify if the speech and language performance of children with MS whose mothers reported use of misoprostol (Cytotec, Pfizer, Connecticut, USA) are different from the performance of children of mothers who did not report use. Methods The stomatognathic system beyond receptive and expressive language and speech was evaluated in children with MS, and their mothers were questioned whether they used misoprostol during the pregnancy. Results During the interview, 61.11% of mothers reported that they took misoprostol during the pregnancy. Most of the subjects (83.3%) whose mothers took misoprostol presented bilateral palsy beyond bad mobility of the tongue (90.9%) and speech disorders (63.6%). Conclusion The number of mothers who took misoprostol without knowing the risk for MS was great. The lack of facial expressions and speech disorders were common characteristics of the individuals with MS, whether the mothers took misoprostol during the pregnancy or not.Universidade Federal de São Paulo (UNIFESP) Escola Paulista de Medicina Department of Speech and LanguageUNIFESP, EPM, Department of Speech and LanguageSciELOFundação OtorrinolaringologiaUniversidade Federal de São Paulo (UNIFESP)Guedes, Zelita Caldeira Ferreira2015-06-14T13:47:16Z2015-06-14T13:47:16Z2014-09-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion239-243application/pdfhttp://dx.doi.org/10.1055/s-0033-1363466International Archives of Otorhinolaryngology. Fundação Otorrinolaringologia, v. 18, n. 3, p. 239-243, 2014.10.1055/s-0033-1363466S1809-48642014000300239.pdf1809-4864S1809-48642014000300239http://repositorio.unifesp.br/handle/11600/8566engInternational Archives of Otorhinolaryngologyinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-08-05T08:07:16Zoai:repositorio.unifesp.br/:11600/8566Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-08-05T08:07:16Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false |
dc.title.none.fl_str_mv |
Möbius Syndrome: Misoprostol Use and Speech and Language Characteristics |
title |
Möbius Syndrome: Misoprostol Use and Speech and Language Characteristics |
spellingShingle |
Möbius Syndrome: Misoprostol Use and Speech and Language Characteristics Guedes, Zelita Caldeira Ferreira misoprostol speech disorders rehabilitation of speech and language disorders |
title_short |
Möbius Syndrome: Misoprostol Use and Speech and Language Characteristics |
title_full |
Möbius Syndrome: Misoprostol Use and Speech and Language Characteristics |
title_fullStr |
Möbius Syndrome: Misoprostol Use and Speech and Language Characteristics |
title_full_unstemmed |
Möbius Syndrome: Misoprostol Use and Speech and Language Characteristics |
title_sort |
Möbius Syndrome: Misoprostol Use and Speech and Language Characteristics |
author |
Guedes, Zelita Caldeira Ferreira |
author_facet |
Guedes, Zelita Caldeira Ferreira |
author_role |
author |
dc.contributor.none.fl_str_mv |
Universidade Federal de São Paulo (UNIFESP) |
dc.contributor.author.fl_str_mv |
Guedes, Zelita Caldeira Ferreira |
dc.subject.por.fl_str_mv |
misoprostol speech disorders rehabilitation of speech and language disorders |
topic |
misoprostol speech disorders rehabilitation of speech and language disorders |
description |
Introduction Möbius syndrome (MS; VI and VII palsy) is a rare disease that in Brazil has a great frequency because of the use of misoprostol during pregnancy. Objective Verify if the speech and language performance of children with MS whose mothers reported use of misoprostol (Cytotec, Pfizer, Connecticut, USA) are different from the performance of children of mothers who did not report use. Methods The stomatognathic system beyond receptive and expressive language and speech was evaluated in children with MS, and their mothers were questioned whether they used misoprostol during the pregnancy. Results During the interview, 61.11% of mothers reported that they took misoprostol during the pregnancy. Most of the subjects (83.3%) whose mothers took misoprostol presented bilateral palsy beyond bad mobility of the tongue (90.9%) and speech disorders (63.6%). Conclusion The number of mothers who took misoprostol without knowing the risk for MS was great. The lack of facial expressions and speech disorders were common characteristics of the individuals with MS, whether the mothers took misoprostol during the pregnancy or not. |
publishDate |
2014 |
dc.date.none.fl_str_mv |
2014-09-01 2015-06-14T13:47:16Z 2015-06-14T13:47:16Z |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.1055/s-0033-1363466 International Archives of Otorhinolaryngology. Fundação Otorrinolaringologia, v. 18, n. 3, p. 239-243, 2014. 10.1055/s-0033-1363466 S1809-48642014000300239.pdf 1809-4864 S1809-48642014000300239 http://repositorio.unifesp.br/handle/11600/8566 |
url |
http://dx.doi.org/10.1055/s-0033-1363466 http://repositorio.unifesp.br/handle/11600/8566 |
identifier_str_mv |
International Archives of Otorhinolaryngology. Fundação Otorrinolaringologia, v. 18, n. 3, p. 239-243, 2014. 10.1055/s-0033-1363466 S1809-48642014000300239.pdf 1809-4864 S1809-48642014000300239 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
International Archives of Otorhinolaryngology |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
239-243 application/pdf |
dc.publisher.none.fl_str_mv |
Fundação Otorrinolaringologia |
publisher.none.fl_str_mv |
Fundação Otorrinolaringologia |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UNIFESP instname:Universidade Federal de São Paulo (UNIFESP) instacron:UNIFESP |
instname_str |
Universidade Federal de São Paulo (UNIFESP) |
instacron_str |
UNIFESP |
institution |
UNIFESP |
reponame_str |
Repositório Institucional da UNIFESP |
collection |
Repositório Institucional da UNIFESP |
repository.name.fl_str_mv |
Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP) |
repository.mail.fl_str_mv |
biblioteca.csp@unifesp.br |
_version_ |
1814268274304614400 |